首页 › 基金 › Decheng Capital LLC › AARD
Decheng Capital LLC 对 AARD 的持仓历史
AARDVARK THERAPEUTICS INC · 医疗保健
Decheng Capital LLC 在 Q3 2026 的 13F 申报中披露持有 AARD(AARDVARK THERAPEUTICS INC)3,917,299 股,市值约 US$20.6M,约占其申报组合的 3.01%,在其申报持仓中市值排名第 4 位。 Decheng Capital LLC 最近 7 个申报季度中有 7 个季度披露了 AARD 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Decheng Capital LLC 对 AARD 的持仓演变
Decheng Capital LLC 于 Q1 2025 首次披露 AARD 持仓:3,917,299 股(约 US$29.4M)。 该持仓在 Q2 2025 达到峰值 3,917,299 股,市值约 US$53.0M。 在 7 次申报中,Decheng Capital LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 3,917,299 股、市值约 US$20.6M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 3.92M | $29.42M | 新进 |
| Q2 2025 | 3.92M | $52.96M | 持有 |
| Q3 2025 | 3.92M | $52.06M | 持有 |
| Q4 2025 | 3.92M | $51.41M | 持有 |
| Q1 2026 | 3.92M | $14.77M | 持有 |
| Q2 2026 | 3.92M | $22.56M | 持有 |
| Q3 2026 | 3.92M | $20.64M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AARD 与 13F 数据
AARD(AARDVARK THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 55 只申报持有 AARD,申报仓位最大的包括:EcoR1 Capital, LLC (US$85K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Decheng Capital LLC
常见问题
How long has Decheng Capital LLC held AARD?
Decheng Capital LLC has disclosed AARD holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Decheng Capital LLC's current position in AARD?
As of Q3 2026, Decheng Capital LLC holds 3.92M shares of AARD (AARDVARK THERAPEUTICS INC), valued at $20.64M, representing 3.01% of its reported portfolio and ranking #4.
Has Decheng Capital LLC been buying or selling AARD?
In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in AARD. The position peaked in Q2 2025 at 3.92M shares.
Which other funds hold AARD?
Other major institutional holders of AARD include EcoR1 Capital, LLC, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.